PHARMACOKINETICS OF ONCE-DAILY INTRAVENOUS BUSULFAN IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Utano, Tomoyuki [1 ]
Sakaguchi, Hirotoshi [2 ]
Gocho, Yoshihiro [2 ]
Osumi, Tomoo [2 ]
Iguchi, Akihiro [2 ]
Tomizawa, Daisuke [2 ]
Matsumoto, Kimikazu [2 ]
Matsumoto, Kana [3 ]
Kato, Motohiro [2 ,4 ]
Yamatani, Akimasa [1 ]
机构：
[1] Natl Ctr Child Hlth & Dev, Dept Pharmaceut, Tokyo, Japan
[2] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan
[3] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Kyoto, Japan
[4] Univ Tokyo, Dept Pediat, Tokyo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS8-1
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation
    Miki Sato
    Shinichi Kako
    Kana Matsumoto
    Kumi Oshima
    Yu Akahoshi
    Hirofumi Nakano
    Tomotaka Ugai
    Ryoko Yamasaki
    Hidenori Wada
    Yuko Ishihara
    Kana Sakamoto
    Koji Kawamura
    Masahiro Ashizawa
    Kiriko Terasako-Saito
    Shun-ichi Kimura
    Hideki Nakasone
    Misato Kikuchi
    Aki Tanihara
    Rie Yamazaki
    Yukie Tanaka
    Junya Kanda
    Junji Nishida
    Kunihiko Morita
    Yoshinobu Kanda
    International Journal of Hematology, 2015, 101 : 497 - 504
  • [2] Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation
    Sato, Miki
    Kako, Shinichi
    Matsumoto, Kana
    Oshima, Kumi
    Akahoshi, Yu
    Nakano, Hirofumi
    Ugai, Tomotaka
    Yamasaki, Ryoko
    Wada, Hidenori
    Ishihara, Yuko
    Sakamoto, Kana
    Kawamura, Koji
    Ashizawa, Masahiro
    Terasako-Saito, Kiriko
    Kimura, Shun-ichi
    Nakasone, Hideki
    Kikuchi, Misato
    Tanihara, Aki
    Yamazaki, Rie
    Tanaka, Yukie
    Kanda, Junya
    Nishida, Junji
    Morita, Kunihiko
    Kanda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (05) : 497 - 504
  • [3] Once-daily intravenous busulfan in children undergoing conditioning for stem cell transplantation: pharmacokinetics and clinical results
    Bredius, RGM
    Zwaveling, J
    den Hartigh, J
    Boelens, J
    Lankester, AC
    Wulffraat, NM
    Guchelaar, HJ
    Egeler, RM
    BONE MARROW TRANSPLANTATION, 2006, 37 : S202 - S202
  • [4] Once-daily intravenous busulfan in children undergoing conditioning for stem cell transplantation: pharmacokinetics and clinical results
    Zwaveling, J
    den Hartigh, J
    Boelens, JJ
    Lankester, AC
    Guchelaar, HJ
    Egeler, M
    Bredius, RG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (04) : 486 - 486
  • [5] Once-daily Intravenous Busulfan for 47 Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Single Center Study
    Gonzalez-Vicent, Marta
    Molina, Blanca
    Perez, Antonio
    Angel Diaz, Miguel
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, 34 (03) : 180 - 183
  • [6] Once-daily intravenous busulfan versus oral busulfan in children prior to stem cell transplantation: study of pharmacokinetics and clinical outcomes
    Boelens, J. J.
    Bartelink, I.
    Bredius, R.
    Zwaveling, J.
    Bierings, M.
    Rademaker, K.
    Ververs, T.
    van Kesteren, C.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S12 - S12
  • [7] Once-daily intravenous Busulfan versus oral Busulfan in children prior to stem cell transplantation: Study of pharmacokinetics and clinical outcomes
    Boelens, J. J.
    Bartelink, I.
    Bredius, R.
    Zwaveling, J.
    Bierings, M.
    Rademaker, K.
    Ververs, T.
    Kesteren, C. van
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 58 - 59
  • [8] Once-daily intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics and early clinical outcomeos
    Zwaveling, Juliette
    den Hartigh, Jan
    Lankester, Arjan C.
    Guchelaar, Henk-Jan
    Egeler, R. Maarten
    Bredius, Robbert G. Maarten
    ANTI-CANCER DRUGS, 2006, 17 (09) : 1099 - 1105
  • [9] PHARMACOKINETICS AND SAFETY OF ONCE-DAILY INTRAVENOUS BUSULFAN WITH BORTEZOMIB IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA UNDERGOING A SECOND AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Freytes, C. O.
    Toro, J. J.
    Yeh, R. F.
    Stadtmauer, E. A.
    Ratanatharathorn, V
    Akpek, G.
    Sahovic, E.
    Tricot, G. J.
    Shaughnessy, P. J.
    White, D. J.
    Rodriguez, T. E.
    Solomon, S. R.
    Yu, L.
    Patil, S.
    Sun, Y.
    Armstrong, E.
    Elekes, A.
    Kato, K.
    Reece, D. E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S253 - S253
  • [10] Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation
    A Jenke
    J Freiberg-Richter
    C Johne
    H Knoth
    E Schleyer
    G Ehninger
    M Bornhäuser
    Bone Marrow Transplantation, 2005, 35 : 627 - 628
12345